Menu

Kano Taskforce Seals Pharmaceutical Company Over Alleged Illegal Distribution of Pregabalin

Admin 2 days ago

The Kano State Multi-Agency Taskforce on Drug Abuse and Illicit Trafficking has sealed a pharmaceutical company in Sabon Gari, Kano, over alleged illegal distribution of controlled drugs, particularly Pregabalin.

The Chairman of the Taskforce, Barr. Muhuyi Magaji, disclosed this on Saturday while conducting journalists round the facility, where he said 3,180,000 tablets of Pregabalin, valued at over N900 million, were recovered.

Magaji said the discovery was part of the taskforce’s intensified efforts to dismantle illegal drug distribution networks and curb the growing abuse of controlled substances in the state.

He disclosed that the taskforce had so far recorded 1,760 arrests and secured 890 convictions in its operations against drug abuse, illicit trafficking and related criminal activities.

The chairman, however, expressed concern that while the taskforce was making efforts to arrest and prosecute drug users, some pharmaceutical companies allegedly licensed by regulatory authorities were contributing to the supply of controlled substances.

He specifically accused some officials of the Pharmaceutical Council of Nigeria (PCN) and the National Agency for Food and Drug Administration and Control (NAFDAC) in Kano of allegedly facilitating the illegal distribution of Pregabalin and other controlled medicines.

According to him, Pregabalin remains the most widely abused substance in Kano, with eight out of every 10 suspected drug users arrested by the taskforce either found with the substance or admitting to its abuse.

Magaji questioned the circumstances surrounding the issuance of import licences for Pregabalin, particularly following its classification as a controlled drug by NAFDAC on September 14, 2026.

He also raised concerns over an import licence allegedly issued to a pharmaceutical company in Kano on October 23, 2026, insisting that the matter required thorough investigation.

The taskforce chairman further alleged that preliminary investigations indicated that the owner of the company had established another firm allegedly being used as a front for the unlawful distribution of controlled medicines through clandestine networks.

He also raised concerns over the alleged registration and operation of the premises within a residential area, questioning compliance with relevant regulatory and land-use requirements.

Magaji alleged that some personnel of the PCN had links with clandestine drug distribution activities, adding that such interests were undermining efforts to address the menace.

“I cannot in good conscience continue to go after the victims (users) while the perpetrators (dealers) are given shield by those that have a statutory responsibility of protecting them from accessing these drugs they tend to abuse,” he said.

Efforts to obtain reactions from the regulatory agencies were unsuccessful as of the time of filing this report.